Report Cover

Global and China Oral Antidiabetic (OAD) Treatment Market Size, Status and Forecast 2021-2027


Global Oral Antidiabetic (OAD) Treatment Scope and Market Size
Oral Antidiabetic (OAD) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Antidiabetic (OAD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
    Sulphonylureas
    Biguanides
    Intestinal ??-Glucosidase Inhibitors
    Others

Segment by Application
    Hospital
    Clinics
    Diabetics Treatment Centres
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

By Company
    Pfizer
    Eli Lilly
    Merck
    Sanofi
    AstraZeneca
    Glenmark
    Novartis
    Boehringer Ingelheim
    Novo Nordisk
    Mannkind
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Sulphonylureas
        1.2.3 Biguanides
        1.2.4 Intestinal ??-Glucosidase Inhibitors
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Oral Antidiabetic (OAD) Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinics
        1.3.4 Diabetics Treatment Centres
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Oral Antidiabetic (OAD) Treatment Market Perspective (2016-2027)
    2.2 Oral Antidiabetic (OAD) Treatment Growth Trends by Regions
        2.2.1 Oral Antidiabetic (OAD) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Oral Antidiabetic (OAD) Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Oral Antidiabetic (OAD) Treatment Industry Dynamic
        2.3.1 Oral Antidiabetic (OAD) Treatment Market Trends
        2.3.2 Oral Antidiabetic (OAD) Treatment Market Drivers
        2.3.3 Oral Antidiabetic (OAD) Treatment Market Challenges
        2.3.4 Oral Antidiabetic (OAD) Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Oral Antidiabetic (OAD) Treatment Players by Revenue
        3.1.1 Global Top Oral Antidiabetic (OAD) Treatment Players by Revenue (2016-2021)
        3.1.2 Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Oral Antidiabetic (OAD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Oral Antidiabetic (OAD) Treatment Revenue
    3.4 Global Oral Antidiabetic (OAD) Treatment Market Concentration Ratio
        3.4.1 Global Oral Antidiabetic (OAD) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic (OAD) Treatment Revenue in 2020
    3.5 Oral Antidiabetic (OAD) Treatment Key Players Head office and Area Served
    3.6 Key Players Oral Antidiabetic (OAD) Treatment Product Solution and Service
    3.7 Date of Enter into Oral Antidiabetic (OAD) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Antidiabetic (OAD) Treatment Breakdown Data by Type
    4.1 Global Oral Antidiabetic (OAD) Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Type (2022-2027)

5 Oral Antidiabetic (OAD) Treatment Breakdown Data by Application
    5.1 Global Oral Antidiabetic (OAD) Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Oral Antidiabetic (OAD) Treatment Market Size (2016-2027)
    6.2 North America Oral Antidiabetic (OAD) Treatment Market Size by Type
        6.2.1 North America Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021)
        6.2.2 North America Oral Antidiabetic (OAD) Treatment Market Size by Type (2022-2027)
        6.2.3 North America Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2027)
    6.3 North America Oral Antidiabetic (OAD) Treatment Market Size by Application
        6.3.1 North America Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2021)
        6.3.2 North America Oral Antidiabetic (OAD) Treatment Market Size by Application (2022-2027)
        6.3.3 North America Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2027)
    6.4 North America Oral Antidiabetic (OAD) Treatment Market Size by Country
        6.4.1 North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2016-2021)
        6.4.2 North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Oral Antidiabetic (OAD) Treatment Market Size (2016-2027)
    7.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type
        7.2.1 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2027)
    7.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application
        7.3.1 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2027)
    7.4 Europe Oral Antidiabetic (OAD) Treatment Market Size by Country
        7.4.1 Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type
        8.2.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application
        8.3.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region
        8.4.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size (2016-2027)
    9.2 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Type
        9.2.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2027)
    9.3 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Application
        9.3.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2027)
    9.4 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country
        9.4.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type
        10.2.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application
        10.3.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country
        10.4.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Oral Antidiabetic (OAD) Treatment Introduction
        11.1.4 Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
        11.1.5 Pfizer Recent Development
    11.2 Eli Lilly
        11.2.1 Eli Lilly Company Details
        11.2.2 Eli Lilly Business Overview
        11.2.3 Eli Lilly Oral Antidiabetic (OAD) Treatment Introduction
        11.2.4 Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
        11.2.5 Eli Lilly Recent Development
    11.3 Merck
        11.3.1 Merck Company Details
        11.3.2 Merck Business Overview
        11.3.3 Merck Oral Antidiabetic (OAD) Treatment Introduction
        11.3.4 Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
        11.3.5 Merck Recent Development
    11.4 Sanofi
        11.4.1 Sanofi Company Details
        11.4.2 Sanofi Business Overview
        11.4.3 Sanofi Oral Antidiabetic (OAD) Treatment Introduction
        11.4.4 Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
        11.4.5 Sanofi Recent Development
    11.5 AstraZeneca
        11.5.1 AstraZeneca Company Details
        11.5.2 AstraZeneca Business Overview
        11.5.3 AstraZeneca Oral Antidiabetic (OAD) Treatment Introduction
        11.5.4 AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
        11.5.5 AstraZeneca Recent Development
    11.6 Glenmark
        11.6.1 Glenmark Company Details
        11.6.2 Glenmark Business Overview
        11.6.3 Glenmark Oral Antidiabetic (OAD) Treatment Introduction
        11.6.4 Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
        11.6.5 Glenmark Recent Development
    11.7 Novartis
        11.7.1 Novartis Company Details
        11.7.2 Novartis Business Overview
        11.7.3 Novartis Oral Antidiabetic (OAD) Treatment Introduction
        11.7.4 Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
        11.7.5 Novartis Recent Development
    11.8 Boehringer Ingelheim
        11.8.1 Boehringer Ingelheim Company Details
        11.8.2 Boehringer Ingelheim Business Overview
        11.8.3 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Introduction
        11.8.4 Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
        11.8.5 Boehringer Ingelheim Recent Development
    11.9 Novo Nordisk
        11.9.1 Novo Nordisk Company Details
        11.9.2 Novo Nordisk Business Overview
        11.9.3 Novo Nordisk Oral Antidiabetic (OAD) Treatment Introduction
        11.9.4 Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
        11.9.5 Novo Nordisk Recent Development
    11.10 Mannkind
        11.10.1 Mannkind Company Details
        11.10.2 Mannkind Business Overview
        11.10.3 Mannkind Oral Antidiabetic (OAD) Treatment Introduction
        11.10.4 Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
        11.10.5 Mannkind Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Sulphonylureas Table 3. Key Players of Biguanides Table 4. Key Players of Intestinal ?-Glucosidase Inhibitors Table 5. Key Players of Others Table 6. Global Oral Antidiabetic (OAD) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Oral Antidiabetic (OAD) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Oral Antidiabetic (OAD) Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Oral Antidiabetic (OAD) Treatment Market Share by Regions (2016-2021) Table 10. Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Oral Antidiabetic (OAD) Treatment Market Share by Regions (2022-2027) Table 12. Oral Antidiabetic (OAD) Treatment Market Trends Table 13. Oral Antidiabetic (OAD) Treatment Market Drivers Table 14. Oral Antidiabetic (OAD) Treatment Market Challenges Table 15. Oral Antidiabetic (OAD) Treatment Market Restraints Table 16. Global Oral Antidiabetic (OAD) Treatment Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Oral Antidiabetic (OAD) Treatment Market Share by Players (2016-2021) Table 18. Global Top Oral Antidiabetic (OAD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Antidiabetic (OAD) Treatment as of 2020) Table 19. Ranking of Global Top Oral Antidiabetic (OAD) Treatment Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Oral Antidiabetic (OAD) Treatment Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Oral Antidiabetic (OAD) Treatment Product Solution and Service Table 23. Date of Enter into Oral Antidiabetic (OAD) Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021) (US$ Million) Table 26. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Type (2016-2021) Table 27. Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Oral Antidiabetic (OAD) Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Application (2016-2021) Table 31. Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021) (US$ Million) Table 34. North America Oral Antidiabetic (OAD) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2021) (US$ Million) Table 36. North America Oral Antidiabetic (OAD) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2022-2027) & (US$

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us